Zark Parking Solutions | Undisclosed Amount | (Jun 13, 2025)
Ryght | $3,000,000 | (Jun 13, 2025)
VectorWave Corporation | $2,500,000 | (Jun 13, 2025)
Certified by Founder
Lodge
Deverra Therapeutics
start up
United States
- Seattle
- 20/09/2023
- Unknown
- $2,400,000
Deverra Therapeutics is a clinical stage biotechnology company dedicated to the development of allogeneic, off-the-shelf cellular immunotherapies for on-demand treatment of patients with cancer and infectious diseases. The company has an exclusive license to a proprietary stem cell expansion and directed-differentiation platform from the Fred Hutchinson Cancer Research Center based on more than 20 years of federally funded research and data from 5 clinical trials. This platform can be used to generate a range of unmodified and modified immune cells to treat patients with cancer and infectious diseases.
- Industry Biotechnology
- Website https://www.deverratx.com/
- LinkedIn https://www.linkedin.com/company/deverra-therapeutics/about/
OneBalance | $20,000,000 | (Jun 13, 2025)
Tastewise | $50,000,000 | (Jun 13, 2025)
Parallel Bio | $21,000,000 | (Jun 13, 2025)
Piston | $7,500,000 | (Jun 13, 2025)
Iterate.ai | $6,400,000 | (Jun 13, 2025)
Tombot | $6,100,000 | (Jun 13, 2025)
SushiDog | $1,761,410 | (Jun 13, 2025)
Knowunity | $31,134,105 | (Jun 13, 2025)
New Iridium | $2,650,000 | (Jun 12, 2025)